Point of Care Molecular Diagnostics Market revenue to cross USD 4.8 Bn by 2027: Global Market Insights Inc.
12 avr. 2021 07h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, April 12, 2021 (GLOBE NEWSWIRE) -- According to latest report “Point of Care (PoC) Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing,...
Point of Care Molecular Diagnostics Market revenue to cross USD 2.8 Bn by 2026: Global Market Insights, Inc.
21 sept. 2020 04h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Sept. 21, 2020 (GLOBE NEWSWIRE) -- According to latest report “PoC Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal...
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
03 mars 2020 08h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting
15 oct. 2019 16h15 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
09 sept. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Oligonucleotide Synthesis Market Worth $2.9 Billion by 2024- Exclusive Report by Meticulous Research®
17 juil. 2019 09h53 HE
|
Meticulous Market Research Pvt. Ltd.
London, July 17, 2019 (GLOBE NEWSWIRE) -- According to this latest publication from Meticulous Research®, the global oligonucleotide synthesis market is expected to grow at a CAGR of 10.5% from 2019...
Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1
31 juil. 2018 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
05 juil. 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
07 juin 2018 07h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...
Fluidigm Releases Sample Identification Genotyping Panel for Translational and Clinical Research
05 juin 2018 06h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification...